Presentation is loading. Please wait.

Presentation is loading. Please wait.

Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles.

Similar presentations


Presentation on theme: "Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles."— Presentation transcript:

1 Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles

2 TimeContentResponsible 08.00am Registration 09.00amOfficial Opening  Workshop objectivesSARPAM  Access to Medicines in Seychelles – a policy overview Ms Lucile de Comarmond  SADC Pharmaceutical Business Plan, SARPAM, TRIPS and Access to Medicines Dr Wilbert Bannenberg  Formal Opening Dr Jude Gedeon Public Health Commissioner  Group Photo 10.00am TEA/COFFEE BREAK WITH PASTRIES

3 Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles

4 Workshop objectives To provide a context how IP policies and the new Industrial Property legislation can impact on Access to Medicines in Seychelles by: Disseminating the comments raised in the lawyers’ meeting Discussing the recommendations with stakeholders from government, health, trade and IP officials, academics, civil society and private sector. To develop a joint understanding of how Seychelles can support future access to medicines, so that these principles can be included in national IP, trade, health and medicines policies.

5 Workshop objectives (2) To develop a stakeholder coordination mechanism to map the way forward and to coordinate the implementation of strategies for taking full advantage of TRIPS flexibilities. To agree on TORs for a multi-stakeholder Technical Working Group on IP and Access to Medicines in Seychelles that will both drive the process and oversee the agenda.

6 Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles

7 SADC Pharmaceutical Business Plan, SARPAM, TRIPS and Access to Medicines Wilbert Bannenberg

8 SADC pharmaceutic al Business Plan

9 SADC Pharmaceutical Business Plan Agreed by Health Ministers in 2006 Follow-up PBP being developed Objective: Access to Medicines for all Has 8 areas of work, inter alia: Pooled procurement & info exchange, Regulatory harmonisation, Local production,  TRIPS impact on Access to Medicines

10 SADC Pharmaceutical Business Plan TRIPS related activities 1.Regional assessment of IP legislation (done) 2.Identify legal resources (done) 3.Database of legal experts (available) 4.Collaborate with partners to enable countries to take full advantage of the flexibilities 5.Avoid TRIPS+ in bilateral trade negotiations

11 Southern African Regional Programme on Access to Medicines (SARPAM) Program Goal: Reduce Disease Burden in SADC by Increasing Access to Quality, Affordable, Essential Medicines Assists SADC Secretariat & member states with the implementation of the SADC Pharmaceutical Business Plan Funded by: DFID (UK),

12 Trade, TRIPS and Access to Medicines Supports SADC PBP TRIPS activities since 2012 SADC member states adopted Sept 2012 concept note 8 member states requested support to review their national IP/patent legislation So far 5 national workshops were held: Botswana, Malawi, Zambia, Zimbabwe, and Lesotho All accepted recommendations to amend Patent legislation Seychelles is 6 th ; Swaziland will be 7 th (October 2014) Next week Regional Lawyers meeting, and Discussion with SADC member states of a strategic plan to produce future generics in SADC that India can no longer easily supply since 2005

13 Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles

14 The Legal Issues 10.30am What are the TRIPS flexibilities? How will their incorporation in patent legislation promote access to essential medicines? Ms Ellen ’t Hoen International Legal Expert 11.00am Seychelles progress in WTO accession Mr Charles Morin Chief Negotiator WTO 11.30am Current IP legislation and its relevance to access to medicines Mr George Robert AG’s Office 12 noon Recommendations of the lawyer’s meeting having done and assessment of the TRIPS flexibilities in the Seychelles IP Act Mr George Robert and Ms Ellen ‘t Hoen 1300 LUNCH 1400 IP legislation and Access to Medicines (panel discussion with all 4 speakers) 1500 Working Groups to discuss details 1600 TEA/COFFEE BREAK 1615 Plenary report of working groups

15 Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles

16 Time Content Responsible 0900am Recap of Day 1 Rapporteurs 09.15am Medicines procurement in Seychelles and challenges Ms Lucile de Comarmond 09.45am Regional Procurement policies and access to medicines – lessons learnt from SADC pool procurement strategy and options for Seychelles Dr Wilbert Bannenberg 10.15am TEA/COFFEE BREAK WITH PASTRIES 10.45am Treatment challenges of 2 nd /3 rd line HIV/AIDS, Hepatitis C in Seychelles Dr Louine Morel In-charge CDCU 11.15am How can Seychelles in future obtain affordable, good quality medicines for HIV/AIDS, Hepatitis C, cancer and other non- communicable diseases? Medical View Dr Wilbert Bannenberg 11.45am Can India supply generic medicines of post-2005 patented products to Seychelles and SADC? Legal view Ms Ellen ’t Hoen Discussion 1300 LUNCH BREAK 1400 Way forward: plenary discussion on Key Recommendations and Roadmap to utilization of TRIPS Flexibilities related to Public Health TEA/COFFEE BREAK Wrap up Chair and Rapporteurs Official Closure Dr Meggy Louange Director General Public Health Authority


Download ppt "Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles."

Similar presentations


Ads by Google